 Apparently, it never got past Phase I clinical trials for this purpose.A wide range of derivatives has been used in pharmaceutical research.Examples include chimeric and humanized minretumomab, as well as a fusion protein of a minretumomab single-chain variable fragment and the enzyme beta-lactamase.